SIX Swiss Exchange · Healthcare
Invest in IVF Hartmann stock from India
Indian and foreign residents can buy IVF Hartmann (VBSN) shares directly through Paasa.
By Paasa · Updated
IVF Hartmann at a glance
- Price
- CHF 129.50+CHF 0.50 (0.39%)
- Market cap
- CHF 308.39M
- Day range
- CHF 129.50 – CHF 129.50
- P/E
- 15.22
- Dividend yield
- 2.93%
- Volume
- 93.00
- 1 month
- -1.15%
- 6 months
- -5.47%
- YTD
- -9.44%
- 1 year
- -6.50%
- 5 years
- -10.69%
IVF Hartmann statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | CHF 161.7M | CHF 158.8M | CHF 148.0M | CHF 150.6M | CHF 144.1M |
| Gross profit | CHF 52.9M | CHF 89.8M | CHF 80.1M | CHF 43.9M | CHF 33.9M |
| Operating income | CHF 17.1M | CHF 23.1M | CHF 16.8M | CHF 13.5M | CHF 1.7M |
| Net income | CHF 18.3M | CHF 20.3M | CHF 15.1M | CHF 11.2M | CHF 6.2M |
| Earnings per share | CHF 7.62 | CHF 8.46 | CHF 6.31 | CHF 4.68 | CHF 2.59 |
| EBITDA | CHF 21.8M | CHF 29.6M | CHF 23.4M | CHF 19.7M | CHF 13.2M |
| Total assets | CHF 196.1M | CHF 189.0M | CHF 188.9M | CHF 180.3M | CHF 173.2M |
| Total debt | CHF 1.4M | CHF 1.3M | CHF 1.3M | CHF 931.0K | CHF 886.0K |
| Cash and short-term investments | CHF 111.8M | CHF 108.9M | CHF 87.9M | CHF 39.8M | CHF 29.3M |
| Shareholders' equity | CHF 155.4M | CHF 152.0M | CHF 151.4M | CHF 143.7M | CHF 137.0M |
| Operating cash flow | CHF 21.5M | CHF 20.4M | CHF 33.8M | CHF 17.7M | −CHF 2.5M |
| Free cash flow | CHF 17.5M | CHF 17.8M | CHF 31.4M | CHF 15.0M | −CHF 9.0M |
| Capital expenditure | −CHF 4.0M | −CHF 2.6M | −CHF 2.4M | −CHF 2.7M | −CHF 6.4M |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in CHF; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Basilea Pharmaceutica | BSLN.SW | CHF 68.30 | CHF 845.32M |
| DocMorris | DOCM.SW | CHF 13.23 | CHF 646.80M |
| COLTENE | CLTN.SW | CHF 46.20 | CHF 276.06M |
| Santhera Pharmaceuticals | SANN.SW | CHF 15.20 | CHF 225.44M |
| Ascom | ASCN.SW | CHF 5.78 | CHF 197.45M |
| Newron Pharmaceuticals | NWRN.SW | CHF 8.35 | CHF 173.73M |
| Molecular Partners | MOLN.SW | CHF 3.34 | CHF 125.29M |
| SHL Telemedicine | SHLTN.SW | CHF 1.07 | CHF 39.65M |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in IVF Hartmann from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to CHF when you buy.
Step 3
Search VBSN and buy
Find IVF Hartmann by name or by its ticker, VBSN, and place your order.
Why invest in IVF Hartmann from India
What IVF Hartmann does
IVF Hartmann Holding AG provides medical consumer goods in Switzerland and internationally. The company offers medical devices; hygiene products, body care, hair care, and breast feeding aids; and disinfectants. IVF Hartmann operates in the Medical - Specialties industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy IVF Hartmann stock from India?
Yes. Indian residents and NRIs can buy IVF Hartmann (VBSN) shares directly through Paasa. IVF Hartmann is listed on the SIX Swiss Exchange, in the Medical - Specialties industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
What tax do I pay in India when I sell IVF Hartmann shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the CHF/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.